EMA — authorised 15 June 2012
- Marketing authorisation holder: Takeda Pharma A/S
- Status: approved
🇪🇺 Feraheme in European Union
EMA authorised Feraheme on 15 June 2012
Marketing authorisation
Feraheme in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in European Union
Frequently asked questions
Is Feraheme approved in European Union?
Yes. EMA authorised it on 15 June 2012.
Who is the marketing authorisation holder for Feraheme in European Union?
Takeda Pharma A/S holds the EU marketing authorisation.